Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign-Reference-Cited by-同舟云学术

Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign

Published:2010-01-15 Issue:2 Volume:116 Page:451-458
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Benz Matthias R.,Czernin Johannes,Dry Sarah M.,Tap William D.,Allen-Auerbach Martin S.,Elashoff David,Phelps Michael E.,Weber Wolfgang A.,Eilber Fritz C.

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.24755/fullpdf

Reference33 articles.

1. Malignant peripheral nerve sheath tumor: molecular pathogenesis and current management considerations;Grobmyer;J Surg Oncol,2008

2. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases;Ducatman;Cancer,1986

3. A clinical study of type 1 neurofibromatosis in north west England;McGaughran;J Med Genet,1999

4. Extremity malignant peripheral nerve sheath tumors (neurogenic sarcomas): a 10-year experience;Vauthey;Ann Surg Oncol,1995

Cited by 181 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malignant Peripheral Nerve Sheath Tumor, a Heterogeneous, Aggressive Cancer with Diverse Biomarkers and No Targeted Standard of Care: Review of the Literature and Ongoing Investigational Agents;Targeted Oncology;2024-07-02

2. Contemporary Approach to Neurofibromatosis Type 1–Associated Malignant Peripheral Nerve Sheath Tumors;American Society of Clinical Oncology Educational Book;2024-06

3. Preoperative Classification of Peripheral Nerve Sheath Tumors on MRI Using Radiomics;Cancers;2024-05-28

4. Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET;Seminars in Nuclear Medicine;2024-05

5. Positron Emission Tomography/Computed Tomography Transformation of Oncology;PET Clinics;2024-04